Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Goldman Sachs Analyst Maintains Sell Rating on Intel with Revised Price Target

Elaine Mendonca by Elaine Mendonca
January 27, 2024
in Breaking News
0
MO stock news
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

On January 27, 2024, Toshiya Hari, an esteemed analyst at Goldman Sachs, has reiterated his bearish stance on Intel (NASDAQ: INTC) by maintaining a “Sell” rating. In a surprising move, Hari has revised the price target upwards from $34 to $39, signaling an even more pessimistic outlook on the company’s stock. This adjustment implies that Goldman Sachs anticipates a decline in Intel’s stock price. Remarkably, the fresh price target reflects a substantial 14.7% surge compared to the prior target of $34.

Intel Corporation (INTC) Stock Plummets by $5.90 or 11.91%: Concerns Rise for Investors

On January 27, 2024, Intel Corporation (INTC) experienced a significant drop in its stock performance. According to data sourced from CNN Money, INTC shares closed at $43.65, which marked a decrease of $5.90 or 11.91% since the market last closed. Furthermore, the stock dropped an additional $0.03 in after-hours trading.

The substantial drop in INTC’s stock price on January 27 raises concerns for investors. The $5.90 decrease represents a significant decline, and the 11.91% drop is a cause for alarm. Investors who held INTC shares would have experienced a considerable loss in value.

The after-hours trading session also saw a further decline of $0.03 in INTC’s stock price. After-hours trading can sometimes be volatile and less liquid compared to regular trading hours. Therefore, this additional drop may indicate continued selling pressure or a lack of confidence in the stock’s short-term prospects.

Investors should consider various factors, including market conditions, industry trends, and company-specific news, before making any investment decisions related to INTC.

INTC Stock Performance on January 27, 2024: A Mixed Bag of Revenue Decline and Steady Earnings

Title: INTC Stock Performance on January 27, 2024: A Mixed Bag of Revenue Decline and Steady Earnings

Introduction:
On January 27, 2024, Intel Corporation’s (INTC) stock performance drew attention as investors analyzed the company’s financial figures. The data reveals a decline in total revenue since the previous year, coupled with a slight increase in revenue from the previous quarter. While net income remained flat compared to the previous quarter, it experienced a significant drop compared to the same period the previous year. Similarly, earnings per share (EPS) remained steady compared to the previous quarter but saw a substantial decline compared to the previous year.

Total Revenue Decline:
Intel Corporation reported total revenue of $54.23 billion in the past year, marking a 14.0% decrease compared to the previous year’s figures. However, total revenue for the fourth quarter of the same year stood at $15.41 billion, indicating an 8.81% increase from the previous quarter.

Net Income Fluctuations:
With a net income of $1.69 billion in the past year, Intel experienced a significant decline of 78.92% compared to the previous year. However, the net income for the fourth quarter of 2023 remained flat at $2.67 billion, indicating stability in the short term.

Earnings per Share Stability:
Intel’s earnings per share (EPS) figures remained steady compared to the previous quarter, with an EPS of $0.63. However, when compared to the same period the previous year, the EPS saw a substantial decline of 79.38%.

Conclusion:
The stock performance of Intel Corporation on January 27, 2024, showcased a decline in total revenue compared to the previous year, but a slight recovery from the previous quarter. The net income figures experienced a significant drop compared to the previous year, while remaining flat compared to the previous quarter. Similarly, earnings per share saw a substantial decline compared to the previous year, but held steady from the previous quarter. These figures indicate a mixed bag of performance for Intel, with potential challenges in revenue growth and profitability. Investors will closely monitor the company’s strategies and future financial reports to assess its ability to overcome these challenges and regain stability in the market.

Tags: INTC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Budgeting (1)

Exciting Quarterly Dividend Announcement from Plumas NASDAQ PLBC

Electric Utilities Stock Exchange

NRG Energy Announces ExDividend Date and Payout Details

Biotechnology Market Capitalization

Analyst Expresses Optimism for Lam Researchs Future Prospects

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com